nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Clindamycin—CYP3A4—prostate cancer	0.018	1	CrCbGaD
Lincomycin—Jaundice—Mitoxantrone—prostate cancer	0.00189	0.00192	CcSEcCtD
Lincomycin—Stomatitis—Mitoxantrone—prostate cancer	0.00189	0.00192	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—prostate cancer	0.00189	0.00192	CcSEcCtD
Lincomycin—Oesophagitis—Prednisone—prostate cancer	0.00189	0.00192	CcSEcCtD
Lincomycin—Rash—Degarelix—prostate cancer	0.00188	0.00191	CcSEcCtD
Lincomycin—Dermatitis—Degarelix—prostate cancer	0.00188	0.00191	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—prostate cancer	0.00187	0.00191	CcSEcCtD
Lincomycin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00186	0.00189	CcSEcCtD
Lincomycin—Angioedema—Conjugated Estrogens—prostate cancer	0.00186	0.00189	CcSEcCtD
Lincomycin—Leukopenia—Goserelin—prostate cancer	0.00184	0.00187	CcSEcCtD
Lincomycin—Vertigo—Conjugated Estrogens—prostate cancer	0.00183	0.00186	CcSEcCtD
Lincomycin—Dermatitis bullous—Docetaxel—prostate cancer	0.00182	0.00185	CcSEcCtD
Lincomycin—Agranulocytosis—Mitoxantrone—prostate cancer	0.00181	0.00184	CcSEcCtD
Lincomycin—Vomiting—Cabazitaxel—prostate cancer	0.00178	0.00182	CcSEcCtD
Lincomycin—Hypersensitivity—Bicalutamide—prostate cancer	0.00177	0.00181	CcSEcCtD
Lincomycin—Nausea—Degarelix—prostate cancer	0.00177	0.0018	CcSEcCtD
Lincomycin—Erythema multiforme—Estradiol—prostate cancer	0.00177	0.0018	CcSEcCtD
Lincomycin—Dermatitis bullous—Capecitabine—prostate cancer	0.00176	0.00179	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—prostate cancer	0.00175	0.00179	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—prostate cancer	0.00175	0.00179	CcSEcCtD
Lincomycin—Tinnitus—Estradiol—prostate cancer	0.00174	0.00177	CcSEcCtD
Lincomycin—Thrombophlebitis—Prednisone—prostate cancer	0.00173	0.00176	CcSEcCtD
Lincomycin—Pancytopenia—Etoposide—prostate cancer	0.00172	0.00175	CcSEcCtD
Lincomycin—Pruritus—Bicalutamide—prostate cancer	0.0017	0.00173	CcSEcCtD
Lincomycin—Neutropenia—Etoposide—prostate cancer	0.00169	0.00172	CcSEcCtD
Lincomycin—Anaphylactic shock—Goserelin—prostate cancer	0.00167	0.0017	CcSEcCtD
Lincomycin—Nausea—Cabazitaxel—prostate cancer	0.00167	0.0017	CcSEcCtD
Lincomycin—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00166	0.00169	CcSEcCtD
Lincomycin—Shock—Goserelin—prostate cancer	0.00165	0.00168	CcSEcCtD
Lincomycin—Diarrhoea—Bicalutamide—prostate cancer	0.00165	0.00168	CcSEcCtD
Lincomycin—Shock—Conjugated Estrogens—prostate cancer	0.00163	0.00166	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—prostate cancer	0.00162	0.00165	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—prostate cancer	0.00162	0.00165	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—prostate cancer	0.00162	0.00165	CcSEcCtD
Lincomycin—Urticaria—Ethinyl Estradiol—prostate cancer	0.00162	0.00165	CcSEcCtD
Lincomycin—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00161	0.00164	CcSEcCtD
Lincomycin—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00161	0.00164	CcSEcCtD
Lincomycin—Liver function test abnormal—Docetaxel—prostate cancer	0.00161	0.00164	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.0016	0.00163	CcSEcCtD
Lincomycin—Stomatitis—Etoposide—prostate cancer	0.00157	0.0016	CcSEcCtD
Lincomycin—Jaundice—Etoposide—prostate cancer	0.00157	0.0016	CcSEcCtD
Lincomycin—Hypotension—Goserelin—prostate cancer	0.00156	0.00159	CcSEcCtD
Lincomycin—Liver function test abnormal—Capecitabine—prostate cancer	0.00155	0.00158	CcSEcCtD
Lincomycin—Colitis—Epirubicin—prostate cancer	0.00155	0.00158	CcSEcCtD
Lincomycin—Hypotension—Conjugated Estrogens—prostate cancer	0.00155	0.00158	CcSEcCtD
Lincomycin—Vomiting—Bicalutamide—prostate cancer	0.00153	0.00156	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—prostate cancer	0.00153	0.00155	CcSEcCtD
Lincomycin—Rash—Bicalutamide—prostate cancer	0.00152	0.00155	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—prostate cancer	0.00152	0.00155	CcSEcCtD
Lincomycin—Dermatitis—Bicalutamide—prostate cancer	0.00152	0.00154	CcSEcCtD
Lincomycin—Agranulocytosis—Etoposide—prostate cancer	0.00151	0.00153	CcSEcCtD
Lincomycin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.0015	0.00153	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—prostate cancer	0.0015	0.00152	CcSEcCtD
Lincomycin—Angioedema—Estradiol—prostate cancer	0.00149	0.00151	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—prostate cancer	0.00148	0.0015	CcSEcCtD
Lincomycin—Vertigo—Estradiol—prostate cancer	0.00146	0.00149	CcSEcCtD
Lincomycin—Pruritus—Ethinyl Estradiol—prostate cancer	0.00144	0.00147	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—prostate cancer	0.00144	0.00146	CcSEcCtD
Lincomycin—Pain—Goserelin—prostate cancer	0.00143	0.00146	CcSEcCtD
Lincomycin—Nausea—Bicalutamide—prostate cancer	0.00143	0.00146	CcSEcCtD
Lincomycin—Pancytopenia—Docetaxel—prostate cancer	0.00143	0.00145	CcSEcCtD
Lincomycin—Pain—Conjugated Estrogens—prostate cancer	0.00142	0.00144	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—prostate cancer	0.00141	0.00144	CcSEcCtD
Lincomycin—Neutropenia—Docetaxel—prostate cancer	0.00141	0.00143	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—prostate cancer	0.0014	0.00143	CcSEcCtD
Lincomycin—Abdominal discomfort—Capecitabine—prostate cancer	0.0014	0.00142	CcSEcCtD
Lincomycin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00139	0.00142	CcSEcCtD
Lincomycin—Pancytopenia—Capecitabine—prostate cancer	0.00138	0.00141	CcSEcCtD
Lincomycin—Erythema multiforme—Etoposide—prostate cancer	0.00137	0.00139	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—prostate cancer	0.00137	0.00139	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—prostate cancer	0.00136	0.00139	CcSEcCtD
Lincomycin—Neutropenia—Capecitabine—prostate cancer	0.00136	0.00139	CcSEcCtD
Lincomycin—Leukopenia—Mitoxantrone—prostate cancer	0.00136	0.00138	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—prostate cancer	0.00136	0.00138	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—prostate cancer	0.00134	0.00137	CcSEcCtD
Lincomycin—Urticaria—Goserelin—prostate cancer	0.00133	0.00135	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.00133	0.00135	CcSEcCtD
Lincomycin—Anaphylactic shock—Estradiol—prostate cancer	0.00133	0.00135	CcSEcCtD
Lincomycin—Abdominal pain—Goserelin—prostate cancer	0.00132	0.00135	CcSEcCtD
Lincomycin—Body temperature increased—Goserelin—prostate cancer	0.00132	0.00135	CcSEcCtD
Lincomycin—Urticaria—Conjugated Estrogens—prostate cancer	0.00132	0.00134	CcSEcCtD
Lincomycin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00131	0.00133	CcSEcCtD
Lincomycin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00131	0.00133	CcSEcCtD
Lincomycin—Stomatitis—Docetaxel—prostate cancer	0.00131	0.00133	CcSEcCtD
Lincomycin—Jaundice—Docetaxel—prostate cancer	0.00131	0.00133	CcSEcCtD
Lincomycin—Shock—Estradiol—prostate cancer	0.00131	0.00133	CcSEcCtD
Lincomycin—Vomiting—Ethinyl Estradiol—prostate cancer	0.00129	0.00132	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.00129	0.00131	CcSEcCtD
Lincomycin—Rash—Ethinyl Estradiol—prostate cancer	0.00128	0.00131	CcSEcCtD
Lincomycin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00128	0.0013	CcSEcCtD
Lincomycin—Stomatitis—Capecitabine—prostate cancer	0.00126	0.00129	CcSEcCtD
Lincomycin—Jaundice—Capecitabine—prostate cancer	0.00126	0.00129	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—prostate cancer	0.00126	0.00128	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—prostate cancer	0.00125	0.00128	CcSEcCtD
Lincomycin—Agranulocytosis—Docetaxel—prostate cancer	0.00125	0.00127	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—prostate cancer	0.00124	0.00126	CcSEcCtD
Lincomycin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00124	0.00126	CcSEcCtD
Lincomycin—Hypersensitivity—Goserelin—prostate cancer	0.00123	0.00126	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—prostate cancer	0.00123	0.00125	CcSEcCtD
Lincomycin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00122	0.00124	CcSEcCtD
Lincomycin—Shock—Mitoxantrone—prostate cancer	0.00122	0.00124	CcSEcCtD
Lincomycin—Neutropenia—Prednisone—prostate cancer	0.00121	0.00123	CcSEcCtD
Lincomycin—Agranulocytosis—Capecitabine—prostate cancer	0.00121	0.00123	CcSEcCtD
Lincomycin—Nausea—Ethinyl Estradiol—prostate cancer	0.00121	0.00123	CcSEcCtD
Lincomycin—Pruritus—Goserelin—prostate cancer	0.00118	0.00121	CcSEcCtD
Lincomycin—Pruritus—Conjugated Estrogens—prostate cancer	0.00117	0.00119	CcSEcCtD
Lincomycin—Hypotension—Mitoxantrone—prostate cancer	0.00116	0.00118	CcSEcCtD
Lincomycin—Diarrhoea—Goserelin—prostate cancer	0.00115	0.00117	CcSEcCtD
Lincomycin—Erythema multiforme—Docetaxel—prostate cancer	0.00114	0.00116	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—prostate cancer	0.00114	0.00116	CcSEcCtD
Lincomycin—Pain—Estradiol—prostate cancer	0.00113	0.00116	CcSEcCtD
Lincomycin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00113	0.00116	CcSEcCtD
Lincomycin—Vertigo—Etoposide—prostate cancer	0.00113	0.00115	CcSEcCtD
Lincomycin—Leukopenia—Etoposide—prostate cancer	0.00113	0.00115	CcSEcCtD
Lincomycin—Erythema multiforme—Capecitabine—prostate cancer	0.0011	0.00112	CcSEcCtD
Lincomycin—Tinnitus—Capecitabine—prostate cancer	0.00109	0.00111	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—prostate cancer	0.00108	0.0011	CcSEcCtD
Lincomycin—Vomiting—Goserelin—prostate cancer	0.00106	0.00108	CcSEcCtD
Lincomycin—Pain—Mitoxantrone—prostate cancer	0.00106	0.00108	CcSEcCtD
Lincomycin—Rash—Goserelin—prostate cancer	0.00106	0.00107	CcSEcCtD
Lincomycin—Dermatitis—Goserelin—prostate cancer	0.00105	0.00107	CcSEcCtD
Lincomycin—Vomiting—Conjugated Estrogens—prostate cancer	0.00105	0.00107	CcSEcCtD
Lincomycin—Urticaria—Estradiol—prostate cancer	0.00105	0.00107	CcSEcCtD
Lincomycin—Body temperature increased—Estradiol—prostate cancer	0.00105	0.00107	CcSEcCtD
Lincomycin—Abdominal pain—Estradiol—prostate cancer	0.00105	0.00107	CcSEcCtD
Lincomycin—Rash—Conjugated Estrogens—prostate cancer	0.00105	0.00106	CcSEcCtD
Lincomycin—Dermatitis—Conjugated Estrogens—prostate cancer	0.00104	0.00106	CcSEcCtD
Lincomycin—Anaphylactic shock—Etoposide—prostate cancer	0.00103	0.00105	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—prostate cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Nausea—Goserelin—prostate cancer	0.000994	0.00101	CcSEcCtD
Lincomycin—Nausea—Conjugated Estrogens—prostate cancer	0.000985	0.001	CcSEcCtD
Lincomycin—Urticaria—Mitoxantrone—prostate cancer	0.000982	0.001	CcSEcCtD
Lincomycin—Hypersensitivity—Estradiol—prostate cancer	0.000978	0.000996	CcSEcCtD
Lincomycin—Abdominal pain—Mitoxantrone—prostate cancer	0.000978	0.000995	CcSEcCtD
Lincomycin—Body temperature increased—Mitoxantrone—prostate cancer	0.000978	0.000995	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—prostate cancer	0.000963	0.000981	CcSEcCtD
Lincomycin—Hypotension—Etoposide—prostate cancer	0.000961	0.000979	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—prostate cancer	0.000948	0.000965	CcSEcCtD
Lincomycin—Pruritus—Estradiol—prostate cancer	0.000939	0.000956	CcSEcCtD
Lincomycin—Leukopenia—Docetaxel—prostate cancer	0.000938	0.000955	CcSEcCtD
Lincomycin—Vertigo—Capecitabine—prostate cancer	0.000911	0.000928	CcSEcCtD
Lincomycin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000911	0.000928	CcSEcCtD
Lincomycin—Diarrhoea—Estradiol—prostate cancer	0.000908	0.000925	CcSEcCtD
Lincomycin—Leukopenia—Capecitabine—prostate cancer	0.000908	0.000924	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000896	0.000913	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—prostate cancer	0.000891	0.000907	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—prostate cancer	0.000881	0.000897	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—prostate cancer	0.000881	0.000897	CcSEcCtD
Lincomycin—Pain—Etoposide—prostate cancer	0.00088	0.000896	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—prostate cancer	0.000877	0.000893	CcSEcCtD
Lincomycin—Anaphylactic shock—Docetaxel—prostate cancer	0.000855	0.00087	CcSEcCtD
Lincomycin—Diarrhoea—Mitoxantrone—prostate cancer	0.000846	0.000862	CcSEcCtD
Lincomycin—Vomiting—Estradiol—prostate cancer	0.000844	0.000859	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—prostate cancer	0.000844	0.000859	CcSEcCtD
Lincomycin—Shock—Docetaxel—prostate cancer	0.000841	0.000856	CcSEcCtD
Lincomycin—Rash—Estradiol—prostate cancer	0.000837	0.000852	CcSEcCtD
Lincomycin—Dermatitis—Estradiol—prostate cancer	0.000836	0.000851	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000829	0.000845	CcSEcCtD
Lincomycin—Angioedema—Prednisone—prostate cancer	0.000825	0.000841	CcSEcCtD
Lincomycin—Urticaria—Etoposide—prostate cancer	0.000817	0.000832	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—prostate cancer	0.000815	0.00083	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—prostate cancer	0.000815	0.00083	CcSEcCtD
Lincomycin—Shock—Capecitabine—prostate cancer	0.000814	0.000829	CcSEcCtD
Lincomycin—Body temperature increased—Etoposide—prostate cancer	0.000813	0.000828	CcSEcCtD
Lincomycin—Abdominal pain—Etoposide—prostate cancer	0.000813	0.000828	CcSEcCtD
Lincomycin—Vertigo—Prednisone—prostate cancer	0.000812	0.000826	CcSEcCtD
Lincomycin—Hypotension—Docetaxel—prostate cancer	0.000799	0.000813	CcSEcCtD
Lincomycin—Nausea—Estradiol—prostate cancer	0.000788	0.000803	CcSEcCtD
Lincomycin—Vomiting—Mitoxantrone—prostate cancer	0.000786	0.000801	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—prostate cancer	0.000781	0.000795	CcSEcCtD
Lincomycin—Rash—Mitoxantrone—prostate cancer	0.00078	0.000794	CcSEcCtD
Lincomycin—Dermatitis—Mitoxantrone—prostate cancer	0.000779	0.000793	CcSEcCtD
Lincomycin—Hypotension—Capecitabine—prostate cancer	0.000773	0.000788	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—prostate cancer	0.000767	0.000781	CcSEcCtD
Lincomycin—Hypersensitivity—Etoposide—prostate cancer	0.000758	0.000772	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—prostate cancer	0.000757	0.000771	CcSEcCtD
Lincomycin—Anaphylactic shock—Prednisone—prostate cancer	0.000737	0.000751	CcSEcCtD
Lincomycin—Nausea—Mitoxantrone—prostate cancer	0.000735	0.000748	CcSEcCtD
Lincomycin—Pain—Docetaxel—prostate cancer	0.000731	0.000744	CcSEcCtD
Lincomycin—Pruritus—Etoposide—prostate cancer	0.000728	0.000741	CcSEcCtD
Lincomycin—Shock—Prednisone—prostate cancer	0.000725	0.000739	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—prostate cancer	0.00071	0.000723	CcSEcCtD
Lincomycin—Pain—Capecitabine—prostate cancer	0.000708	0.000721	CcSEcCtD
Lincomycin—Diarrhoea—Etoposide—prostate cancer	0.000704	0.000717	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—prostate cancer	0.0007	0.000713	CcSEcCtD
Lincomycin—Abdominal pain—Docetaxel—prostate cancer	0.000676	0.000688	CcSEcCtD
Lincomycin—Body temperature increased—Docetaxel—prostate cancer	0.000676	0.000688	CcSEcCtD
Lincomycin—Urticaria—Capecitabine—prostate cancer	0.000657	0.00067	CcSEcCtD
Lincomycin—Abdominal pain—Capecitabine—prostate cancer	0.000654	0.000666	CcSEcCtD
Lincomycin—Body temperature increased—Capecitabine—prostate cancer	0.000654	0.000666	CcSEcCtD
Lincomycin—Vomiting—Etoposide—prostate cancer	0.000654	0.000666	CcSEcCtD
Lincomycin—Rash—Etoposide—prostate cancer	0.000649	0.00066	CcSEcCtD
Lincomycin—Dermatitis—Etoposide—prostate cancer	0.000648	0.00066	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—prostate cancer	0.000635	0.000646	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—prostate cancer	0.000632	0.000644	CcSEcCtD
Lincomycin—Hypersensitivity—Docetaxel—prostate cancer	0.00063	0.000641	CcSEcCtD
Lincomycin—Nausea—Etoposide—prostate cancer	0.000611	0.000622	CcSEcCtD
Lincomycin—Hypersensitivity—Capecitabine—prostate cancer	0.00061	0.000621	CcSEcCtD
Lincomycin—Pruritus—Docetaxel—prostate cancer	0.000605	0.000616	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—prostate cancer	0.000587	0.000598	CcSEcCtD
Lincomycin—Urticaria—Prednisone—prostate cancer	0.000586	0.000596	CcSEcCtD
Lincomycin—Pruritus—Capecitabine—prostate cancer	0.000586	0.000596	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—prostate cancer	0.000585	0.000596	CcSEcCtD
Lincomycin—Diarrhoea—Docetaxel—prostate cancer	0.000585	0.000596	CcSEcCtD
Lincomycin—Body temperature increased—Prednisone—prostate cancer	0.000583	0.000593	CcSEcCtD
Lincomycin—Abdominal pain—Prednisone—prostate cancer	0.000583	0.000593	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—prostate cancer	0.000577	0.000587	CcSEcCtD
Lincomycin—Shock—Epirubicin—prostate cancer	0.000567	0.000578	CcSEcCtD
Lincomycin—Diarrhoea—Capecitabine—prostate cancer	0.000566	0.000577	CcSEcCtD
Lincomycin—Vomiting—Docetaxel—prostate cancer	0.000544	0.000553	CcSEcCtD
Lincomycin—Hypersensitivity—Prednisone—prostate cancer	0.000543	0.000553	CcSEcCtD
Lincomycin—Rash—Docetaxel—prostate cancer	0.000539	0.000549	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—prostate cancer	0.000539	0.000549	CcSEcCtD
Lincomycin—Dermatitis—Docetaxel—prostate cancer	0.000538	0.000548	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—prostate cancer	0.000533	0.000543	CcSEcCtD
Lincomycin—Vomiting—Capecitabine—prostate cancer	0.000526	0.000536	CcSEcCtD
Lincomycin—Shock—Doxorubicin—prostate cancer	0.000525	0.000534	CcSEcCtD
Lincomycin—Rash—Capecitabine—prostate cancer	0.000522	0.000531	CcSEcCtD
Lincomycin—Pruritus—Prednisone—prostate cancer	0.000522	0.000531	CcSEcCtD
Lincomycin—Dermatitis—Capecitabine—prostate cancer	0.000521	0.000531	CcSEcCtD
Lincomycin—Nausea—Docetaxel—prostate cancer	0.000508	0.000517	CcSEcCtD
Lincomycin—Diarrhoea—Prednisone—prostate cancer	0.000504	0.000514	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—prostate cancer	0.000499	0.000508	CcSEcCtD
Lincomycin—Pain—Epirubicin—prostate cancer	0.000493	0.000502	CcSEcCtD
Lincomycin—Nausea—Capecitabine—prostate cancer	0.000492	0.000501	CcSEcCtD
Lincomycin—Vomiting—Prednisone—prostate cancer	0.000469	0.000477	CcSEcCtD
Lincomycin—Rash—Prednisone—prostate cancer	0.000465	0.000473	CcSEcCtD
Lincomycin—Dermatitis—Prednisone—prostate cancer	0.000464	0.000473	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—prostate cancer	0.000458	0.000466	CcSEcCtD
Lincomycin—Pain—Doxorubicin—prostate cancer	0.000456	0.000465	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—prostate cancer	0.000456	0.000464	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—prostate cancer	0.000456	0.000464	CcSEcCtD
Lincomycin—Nausea—Prednisone—prostate cancer	0.000438	0.000446	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—prostate cancer	0.000425	0.000433	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—prostate cancer	0.000424	0.000432	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—prostate cancer	0.000422	0.000429	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—prostate cancer	0.000422	0.000429	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—prostate cancer	0.000408	0.000415	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—prostate cancer	0.000394	0.000402	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—prostate cancer	0.000393	0.0004	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—prostate cancer	0.000377	0.000384	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—prostate cancer	0.000367	0.000373	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—prostate cancer	0.000365	0.000372	CcSEcCtD
Lincomycin—Rash—Epirubicin—prostate cancer	0.000364	0.00037	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—prostate cancer	0.000363	0.00037	CcSEcCtD
Lincomycin—Nausea—Epirubicin—prostate cancer	0.000342	0.000349	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—prostate cancer	0.000339	0.000345	CcSEcCtD
Lincomycin—Rash—Doxorubicin—prostate cancer	0.000336	0.000343	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—prostate cancer	0.000336	0.000342	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—prostate cancer	0.000317	0.000323	CcSEcCtD
